What is (ALOGLIPTIN BENZOATE) VIPIDIA for?

(ALOGLIPTIN BENZOATE) VIPIDIA, also known as TRAJENTA, is a doctor-prescribed medication used in combination with a proper diet and exercise program to manage high blood sugar levels in individuals with type 2 diabetes. Manufactured by TAKEDA Pharma of Ireland, this genuine medication should be taken as directed by your doctor. You can take TRAJENTA tablets with or without food, but it’s advisable to maintain a consistent daily schedule.

Side Effects of (ALOGLIPTIN BENZOATE) VIPIDIA:

Common side effects of (ALOGLIPTIN BENZOATE) VIPIDIA may include sweating, shaking, fast heartbeat, hunger, blurred vision, and dizziness. If any of these side effects persist or worsen, consult your doctor or pharmacist promptly. Your healthcare provider has prescribed this medication because its benefits outweigh the potential risks. While many users do not experience serious side effects, it’s important to contact your doctor immediately if you encounter joint pain, unusual skin blisters, or signs of heart failure, such as shortness of breath, swelling ankles/feet, unusual tiredness, or sudden weight gain. To optimize the benefits of this medication, take it regularly at the same times as directed by your doctor. This list does not cover all possible side effects, so consult your doctor or pharmacist for any other side effects not listed.

Uses of (ALOGLIPTIN BENZOATE) VIPIDIA:

(ALOGLIPTIN BENZOATE) VIPIDIA is utilized alongside a proper diet and exercise regimen to manage high blood sugar in individuals with type 2 diabetes. Effective blood sugar control helps prevent complications such as kidney damage, vision problems, nerve issues, limb loss, and sexual function problems. Furthermore, managing diabetes can reduce the risk of heart attacks or strokes. (ALOGLIPTIN BENZOATE) VIPIDIA operates by increasing the levels of natural substances called incretins, which regulate blood sugar by enhancing insulin release, particularly after meals, and reducing liver sugar production.

How to use (ALOGLIPTIN BENZOATE) VIPIDIA:

Before using (ALOGLIPTIN BENZOATE) VIPIDIA read the Medication Guide provided by your pharmacist. Take this medication by mouth as directed by your doctor, usually once daily, with or without food. The dosage depends on your medical condition and response to treatment. Consistency is key, so take this medication at the same time each day. Additionally, follow your diabetes management plan, including medications, diet, and exercise.

Regularly monitor your blood sugar as directed by your doctor and share the results with them. Notify your doctor if your blood sugar measurements are consistently high or low. Depending on the situation, your doctor may need to adjust your diabetes medication, exercise regimen, or diet.

Precautions:

Inform your doctor or pharmacist if you are allergic to (ALOGLIPTIN BENZOATE) VIPIDIA or have any other allergies. This product may contain inactive ingredients that can trigger allergic reactions or other issues. Discuss your medical history, especially kidney disease, heart failure, liver problems, pancreatitis, or gallstones, before using this medication. Extremely low or high blood sugar may lead to blurred vision, dizziness, or drowsiness. Avoid activities requiring alertness or clear vision until you are confident in your ability to perform them safely. Limit alcohol consumption while taking this medication, as it can increase the risk of low blood sugar. Stress, such as fever, infection, injury, or surgery, may make blood sugar control more challenging. Consult your doctor, as it may necessitate changes in your treatment plan, medications, or blood sugar testing.

Interactions:

Drug interactions can alter how your medications work or increase the risk of serious side effects. This document does not encompass all possible drug interactions, so maintain a list of all products you use and share it with your doctor and pharmacist. Do not start, stop, or modify your medication dosage without your doctor’s approval. Some medications, such as beta-blockers or glaucoma eye drops, may affect the usual fast/pounding heartbeat that occurs when blood sugar drops too low. These drugs may not affect other low blood sugar symptoms, like dizziness, hunger, or sweating. Many drugs can impact blood sugar, making control more challenging. Before altering your medication regimen, speak with your doctor or pharmacist about how your medication may affect blood sugar levels. Regularly monitor your blood sugar as instructed and report any high or low blood sugar symptoms to your doctor. If you experience symptoms of high blood sugar, such as increased thirst and urination, inform your doctor promptly. Seek immediate medical assistance if you have severe symptoms or signs of pancreatitis, dark urine, yellowing eyes/skin, or a serious allergic reaction.

Overdose:

In case of overdose with serious symptoms like loss of consciousness or difficulty breathing, dial 911. For less severe cases, contact a poison control center immediately. US residents can reach their local poison control center at 1-800-222-1222. Canadian residents can contact a provincial poison control center.

Notes:

Do not share this medication with others.

Attend a diabetes education program to learn more about managing your diabetes with medications, diet, exercise, and regular medical exams.

Familiarize yourself with high and low blood sugar symptoms and how to treat low blood sugar. Monitor your blood sugar regularly as directed.

Lab and Medical Tests:

Before starting (ALOGLIPTIN BENZOATE) VIPIDIA, and during its use, medical and lab tests such as kidney/liver function, blood glucose, and hemoglobin A1c should be conducted. Keep all medical and lab appointments and consult your doctor for more details.